Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLSAI.L Regulatory News (LSAI)

  • There is currently no data for LSAI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Final Results

28 Mar 2011 14:17

RNS Number : 7475D
Longships PLC
28 March 2011
 



LONGSHIPS PLC

 

("Longships" or the "Company")

 

 

ANNUAL REPORT FOR THE YEAR ENDED 31st DECEMBER 2010

 

 Longships is pleased to announce its annual results for the year ending 31st December 2010.

 

The accounts are today being posted to the shareholders and are available on the Company's website, www.longshipsplc.com.

 

Enquiries:

 

Longships Plc

Tel: 020 7389 5017

Charles Cannon Brookes, Director

 

Grant Thornton Corporate Finance (Nominated Adviser)

Tel: 020 7383 5100

 

Colin Aaronson/David Hignell

 

 

CHAIRMAN'S STATEMENT

FOR THE YEAR ENDED 31st DECEMBER 2010

 

Dear Shareholder,

 

I am pleased to present my Chairman's report covering the year ended 31st December 2010. During the year under review, the Company reported a loss of £82,439 and as at 31st December 2010 had liquid cash balances of £3,188,206(2009: £3,269,514). Various investment propositions were reviewed during the year and the overheads reflect the abortive costs of proposed transactions. Although none as yet have met the Board's investment criteria, the search continues for a suitable opportunity. I look forward to updating shareholders on progress in due course.

 

Malcolm Burne

Chairman

28th March 2011

 

STATEMENT OF COMPREHENSIVE INCOME

FOR THE YEAR ENDED 31st DECEMBER 2010

Notes

2010

2009

£

£

NET TRADING INCOME

-

-

---------------

---------------

Other operating expenses

(92,843)

(92,417)

------------------

------------------

Total operating expenses

(92,843)

(92,417)

-------------------

-------------------

OPERATING LOSS

(92,843)

(92,417)

Finance income

10,404

8,448

------------------

------------------

LOSS BEFORE TAXATION

(82,439)

(83,969)

Taxation

4

-

(7)

------------------

------------------

LOSS FOR THE YEAR ATTRIBUTABLE TO EQUITY HOLDERS OF THE COMPANY

(82,439)

(83,962)

============

============

Loss per share (pence) - basic and fully diluted

5

(0.36)p

(0.36)p

=======

=======

 

 

STATEMENT OF FINANCIAL POSITION

AS AT 31st DECEMBER 2010

 

 

2010

2009

Notes

£

£

CURRENT ASSETS

Trade and other receivables

6

8,795

8,129

Cash and cash equivalents

3,188,206

3,269,514

------------------

------------------

3,197,001

3,277,643

CURRENT LIABILITIES

Trade and other payables

7

(21,287)

(19,490)

-----------------

-----------------

NET CURRENT ASSETS

3,175,714

3,258,153

----------------

----------------

NET ASSETS

3,175,714

3,258,153

===========

===========

EQUITY ATTRIBUTABLE TO EQUITY HOLDERS OF THE COMPANY

Share capital

8

230,800

230,800

Share premium account

3,086,962

3,086,962

Share based payment reserve

21,588

21,588

Retained earnings

(163,636)

(81,197)

-------------------

-------------------

TOTAL EQUITY

3,175,714

3,258,153

=============

=============

 

 

The financial statements were approved and authorised for issue by the Directors on 28th March 2011 and were signed on their behalf by:

 

 

Charles Cannon Brookes

Director

CASH FLOW STATEMENT

FOR THE YEAR ENDED 31st DECEMBER 2010

 

2010

2009

Notes

£

£

Net cash outflow from operating activities

9

(91,712)

(94,490)

----------------

----------------

Cash flows from investing activities

Interest received

10,404

8,448

----------------

----------------

Cash flows from financing activities

Net proceeds from issue of share capital

-

-

------------------

------------------

Net decrease in cash and cash equivalents

(81,308)

(86,042)

Cash and cash equivalents at beginning of year

3,269,514

3,355,556

------------------

------------------

Cash and cash equivalents at end of year

3,188,206

3,269,514

=============

=============

 

 

STATEMENT OF CHANGES IN NET EQUITY

FOR THE YEAR ENDED 31st DECEMBER 2009

 

Share capital

Share premium

Share based payment reserve

Retained earnings

Total

£

£

£

£

£

At 1st January 2009

230,800

3,086,962

21,588

2,765

3,342,115

Loss for year

-

-

-

(83,962)

(83,962)

________

_________

_________

__________

_________

At 31st December 2009

230,800

3,086,962

21,588

(81,197)

3,258,153

=======

========

========

=========

========

 

 

 

 

STATEMENT OF CHANGES IN NET EQUITY

FOR THE YEAR ENDED 31st DECEMBER 2010

 

Share capital

Share premium

Share based payment reserve

Retained earnings

Total

£

£

£

£

£

At 1st January 2010

230,800

3,086,962

21,588

(81,197)

3,258,153

Loss for year

-

-

-

(82,439)

(82,439)

________

_________

_________

__________

_________

At 31st December 2010

230,800

3,086,962

21,588

(163,636)

3,175,714

=======

========

========

=========

========

 

1. ACCOUNTING POLICIES

 

Basis of preparation

The financial statements have been prepared in accordance with International Financial Reporting Standards ("IFRSs") as adopted by the European Union.

Trading income

Trading income is recognised to the extent that it is probable that economic benefit will flow to the Company and the trading income can be reliably measured.

Cash and cash equivalents

Cash and cash equivalents are defined as cash in hand, demand deposits and short-term, highly liquid investments which are readily convertible to known amounts of cash, subject to insignificant risk of changes in value, and have a maturity of less than 3 months from the date of acquisition.

For the purposes of the cash flow statement, cash and cash equivalents consist of cash in hand and bank deposits.

Taxation

The tax currently payable is based on the taxable profit for the period. Taxable profit differs from net profit as reported in the income statement because it excludes items of income or expense that are taxable or deductible in other periods and it further excludes items that are never taxable or deductible. The Company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the balance sheet date.

Deferred taxation

Deferred income tax is provided for using the liability method on temporary timing differ-ences at the balance sheet date between tax basis of assets and liabilities and their carrying amounts for financial reporting purposes. Deferred tax liabilities are recognised in full for all temporary differences. Deferred tax assets are recognised for all deductible temporary differ-ences carried forward of unused tax credits and unused tax losses to the extent that it is prob-able that taxable profit will be available against which the deductible temporary differences, and carry-forward of unused tax credits and unused losses can be utilised.

The carrying amount of deferred income tax assets is assessed at each balance sheet date and reduced to the extent that it is no longer probable that sufficient taxable profit will be available to allow all or part of the deferred income tax asset to be utilised. Unrecognised deferred income tax assets are reassessed at each balance sheet date and are recognised to the extent that is probable that future taxable profits will allow the deferred tax asset to be recovered.

Deferred income tax assets and liabilities are measured at the tax rates that are expected to apply to the period when the asset is realised or the liability settled, based on tax rates that have been enacted or substantively enacted at the balance sheet date.

Share-based payments

Certain Directors of the Company receive remuneration in the form of share-based payment transactions (equity-settled transactions).

The cost of equity-settled transactions is determined with reference to the fair value at the date on which they were granted. The fair value is determined by using the Black-Scholes option pricing model.

The cost of equity-settled transactions is recognised, together with a corresponding increase in equity, over the period in which the service conditions are fulfilled, ending on the date on which the relevant employees become fully entitled to the award ("the vesting date"). The cumulative expense recognised for equity-settled transactions at each re-porting date until the vesting date reflects the extent to which the vesting period has expired and the Company's best estimate of the number of equity instruments that will ultimately vest. The income statement charge or credit for a period represents the movement in cumulative expense recognised as at the beginning and end of that period.

The dilutive effect of the outstanding options is reflected as additional dilution in the compu-tation of earnings per share.

Financial instruments

 

Financial assets and financial liabilities are recognised on the Company's balance sheet when the Company becomes a contractual party to the instrument.

 

Trade receivables

Trade receivables are recognised initially at their fair value which equates to their nominal value as reduced by appropriate provision for irrecoverable amounts and subsequently at amortised cost.

 

Trade payables

Trade payables are recognised initially at their fair value and subsequently at amortised cost.

 

Accounting judgements and key sources of estimation uncertainty

The preparation of financial statements in accordance with IFRSs requires management to make estimates and assumptions in certain circumstances that affect reported amounts. The most sensitive estimate affecting the financial statements is the area of share based payments. Actual outcomes may therefore differ from these estimates and assumptions.

 

In determining the fair value of equity settled share based payments and the related charge to the income statement, the Company makes assumptions about future events and market conditions. In particular, judgment must be made as to the likely number of shares that will vest and the fair value of each award granted. The fair value is determined using a valuation model which is dependent on further estimates including the Company's future dividend policy, employee turnover, the timing of the exercise of options and the future volatility in the price of the Company's shares.

Such assumptions are based on publicly available information and reflect market expectations. Different assumptions from those used could materially affect the reported value of share based payments. The Company has recognised a corresponding increase in equity in accordance with IFRS 2: Share based payments by crediting "Share based payment reserve" (a component of equity) for the issue of shares in connection with the share options.

 

Standards becoming effective in the year

 

The following new and amended IAS, IFRS and IFRIC Interpretations became effective in the year:

 

·; Revised IFRS 3 Business Combinations

·; Amendments to IAS 27 Consolidated and Separate Financial Statements

·; Amendment to IAS 39 Financial Instruments: Recognition and Measurement: Eligible Hedged Items

·; IFRIC 17 Distributions of Non-cash Assets to Owners Revised IFRS 1 First-time Adoption of International Financial Reporting Standards

·; IFRIC 18 Transfer of Assets from Customers

·; Improvements to IFRSs

·; Group Cash-settled Share-based Payment Transactions (Amendments to IFRS 2)

·; Additional Exemptions for First-time Adopters (Amendments to IFRS 1)

·; Classification of Rights Issues IFRIC 19 Extinguishing Financial Liabilities with Equity Instruments

 

The Directors consider that the introduction of these Standards and Interpretations has no material impact on the financial statements of the Company in its current form.

 

Standards and Interpretations issued but not yet effective

The Company has not early adopted the following new and amended IAS, IFRS and IFRIC Interpretations issued. The relevant new and amended IAS, IFRS and IFRIC Interpretations will be adopted when they become effective.

 

·; Amendments to IFRIC 14 IAS 19 - Limit on a Defined Benefit Asset, Minimum Funding Requirements and their Interaction (effective for accounting periods beginning on or after 1st January 2011)

The Directors anticipate that the adoption of these Standards and Interpretations in future periods will have no material impact on the financial statements of the Company in its current form.

 

 

2. AUDITORS' REMUNERATION

2010

2009

£

£

Services provided by the Company's auditors:

Fees payable to the Company's auditors for the audit of the company's financial statements

18,100

13,800

Fees payable to the Company's auditors for other services:

 - Other services pursuant to legislation

-

1,150

 - Taxation

-

2,013

======

======

 

3. PARTICULARS OF EMPLOYEES

 

The average number of employees of the Company in the year was:

2010

2009

Number

Number

Directors

3

3

======

======

£

£

The Directors' aggregate emoluments in respect of qualifying services were:

Salary and short-term employment benefits

10,000

10,000

Other fees paid

5,875

5,750

----------------

----------------

15,875

15,750

==========

==========

Other fees paid comprise £5,875 (2009: £5,750) paid to Munslows, a firm in which Nathan Steinberg is a partner, in respect of his services as a Director of the Company. A further £1,175 (2009: £nil) was paid to Munslows in respect of accountancy services.

 

 

4. INCOME TAX EXPENSE

 

(a) Analysis of charge in the year

2010

2009

£

£

Current tax:

 

UK corporation tax based on the results for the year at 21% (2009: 21%)

-

-

 

Adjustment to prior year

-

(7)

----------------

----------------

Total current tax

-

(7)

==========

==========

 

(b) Factors affecting the tax charge for the year

The tax assessed for the year does not reflect an expense equivalent to the loss before tax multiplied by the standard rate of corporation tax of 21% (2009: 21%).

2010

2009

£

£

Loss before tax

(82,439)

(83,969)

=========

=========

Loss before tax multiplied by the standard rate of corporation tax

17,312

17,633

Effects of:

Losses carried forward

(17,312)

(17,633)

Adjustment to prior year

-

(7)

------------

------------

Current tax for the year

-

(7)

=========

=========

 

The Company has corporation tax losses available for offset against future profits of the same trade of £165,244 (2009: £83,856). The deferred taxation asset not provided for in the accounts due to the uncertainty that future taxable profits will be available to allow recovery of the asset is approximately £33,049 (2009: £16,707).

 

 

5. LOSS PER SHARE

 

The calculation of loss per share is based on the loss of £82,439 (2009: £83,962) and on the number of shares in issue, being the weighted average number of shares in issue during the year of 23,080,002 (2009: 23,080,002) ordinary £0.01 shares. There is no dilutive effect of share options on the basic earnings per share.

 

 

6. TRADE AND OTHER RECEIVABLES

2010

2009

£

£

Prepayments

8,795

8,129

===============

===============

 

The Directors consider that the carrying value of each class of receivable approximates its fair value.

 

 

7. TRADE AND OTHER PAYABLES

 

2010

2009

£

£

Trade payables

7,287

9,384

Accrued expenses

14,000

10,106

--------------------

--------------------

21,287

19,490

=============

=============

 

 

 

 

 

 

8. SHARE CAPITAL

 

Share options

 

The Company granted and issued share options over ordinary shares in the Company as follows:

 

Date granted

 

Parties

 

Exercise price

 

Number of shares

 

Final exercisable date

21/04/08

Charles Cannon Brookes

20p

500,000

21/04/15

21/04/08

Craig LB Niven

20p

500,000

21/04/15

-------------------

1,000,000

Options outstanding at 31/12/09 and 31/12/10

1,000,000

=============

 

Authorised share capital:

2010

2009

£

£

100,000,000 Ordinary shares of £0.01 each

1,000,000

1,000,000

==========================================

==========================================

 

Allotted, called up and fully paid:

2010

2009

£

£

23,080,002 Ordinary shares of £0.01 each

230,800

230,800

===================================

===================================

 

 

9. CASH FLOWS FROM OPERATING ACTIVITIES

2010

2009

£

£

Loss before taxation

(82,439)

(83,969)

Adjustments for:

Interest income

(10,404)

(8,448)

Taxation paid

-

--------------------

(6,370)

--------------------

(92,843)

(98,787)

(Increase)/decrease in receivables

(666)

954

Increase in payables

1,797

3,343

--------------------

--------------------

Net cash outflow from operating activities

(91,712)

(94,490)

=============

=============

 

 

10. FINANCIAL INSTRUMENTS

 

Financial assets and liabilities were held as follows:

2010

2009

Assets

£

£

Cash and cash equivalents

3,188,206

3,269,514

--------------------

--------------------

Total financial assets

3,188,206

3,269,514

=============

=============

Liabilities

Trade payables

7,287

9,384

Accrued expenses

14,000

10,106

--------------------

--------------------

Total financial liabilities

21,287

19,490

=============

=============

 

The Directors consider that the carrying value of the financial assets and liabilities approximates their fair value.

 

 

11. GENERAL INFORMATION

 

Longships Plc is a public limited company incorporated and domiciled in England and Wales. The Company does not have an ultimate controlling party.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FR BXGDXDBDBGBI
Date   Source Headline
16th Feb 202412:30 pmRNSResult of General Meeting
6th Feb 202410:55 amRNSHolding(s) in Company
30th Jan 20248:00 amRNSSchedule One - Location Sciences Group Plc
30th Jan 20247:30 amRNSRestoration - Location Sciences Group PLC
30th Jan 20247:00 amRNSAcquisition and Publication of Admission Document
25th Jan 20247:00 amRNSLoan Facility and Holding in Company
20th Dec 20237:00 amRNSFurther update on proposed acquisition of Sorted
6th Oct 20237:00 amRNSUpdate on proposed acquisition of Sorted
14th Sep 20237:00 amRNSHalf-year Report
28th Jul 20231:22 pmRNSResult of AGM
25th Jul 20237:00 amRNSHolding(s) in Company
28th Jun 20237:30 amRNSSuspension - Location Sciences Group plc
28th Jun 20237:00 amRNSLoan Agreement, Proposed Acquisition & Suspension
26th Jun 20237:00 amRNSAnnual Financial Report
11th Apr 20234:56 pmRNSHolding(s) in Company
31st Mar 202311:50 amRNSHolding(s) in Company
27th Mar 20237:00 amRNSHolding(s) in Company
22nd Mar 20233:47 pmRNSHolding(s) in Company
22nd Mar 20231:40 pmRNSHolding(s) in Company
22nd Mar 20239:05 amRNSSecond Price Monitoring Extn
22nd Mar 20239:00 amRNSPrice Monitoring Extension
15th Mar 20234:35 pmRNSPrice Monitoring Extension
9th Mar 20234:35 pmRNSPrice Monitoring Extension
27th Sep 20227:00 amRNSHalf-year Report
30th Jun 202211:56 amRNSResult of AGM
6th Jun 20227:00 amRNSNotice of Annual General Meeting
1st Jun 20222:12 pmRNSDirector/PDMR Shareholding
1st Jun 20221:25 pmRNSDirector/PDMR Shareholding
1st Jun 20227:00 amRNSBoard and strategic update
5th Apr 202211:05 amRNSSecond Price Monitoring Extn
5th Apr 202211:00 amRNSPrice Monitoring Extension
30th Mar 20227:00 amRNSAnnual Financial Report
1st Feb 20227:00 amRNSFurther re Sale of Insights dashboard
24th Jan 202211:05 amRNSSecond Price Monitoring Extn
24th Jan 202211:01 amRNSPrice Monitoring Extension
22nd Oct 20218:05 amRNSSale of Insights dashboard
27th Sep 202112:09 pmRNSHalf-year Report
21st Jun 20211:27 pmRNSBusiness Review update and proposed Board changes
21st Jun 202111:28 amRNSHolding(s) in Company
18th Jun 202110:55 amRNSResult of AGM
11th Jun 202110:34 amRNSHolding(s) in Company
8th Jun 202111:54 amRNSHolding(s) in Company
1st Jun 20219:06 amRNSSecond Price Monitoring Extn
1st Jun 20219:00 amRNSPrice Monitoring Extension
28th May 20215:00 pmRNSTotal Voting Rights
28th May 20212:11 pmRNSHolding(s) in Company
27th May 20213:33 pmRNSTR-1 Notification of major holdings
25th May 20218:05 amRNSNotice of AGM
25th May 20218:01 amRNSBoard changes and appointment of Joint Broker
21st May 202111:14 amRNSGM Result, Issue of Equity and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.